Does OLARATUMAB Cause Therapy non-responder? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy non-responder have been filed in association with OLARATUMAB. This represents 0.9% of all adverse event reports for OLARATUMAB.
5
Reports of Therapy non-responder with OLARATUMAB
0.9%
of all OLARATUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From OLARATUMAB?
Of the 5 reports, and 4 (80.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLARATUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does OLARATUMAB Cause?
Off label use (124)
Neutropenia (66)
Infusion related reaction (64)
Febrile neutropenia (57)
Drug ineffective (49)
Death (44)
Malignant neoplasm progression (43)
Product use in unapproved indication (40)
Disease progression (33)
Anaphylactic reaction (29)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which OLARATUMAB Alternatives Have Lower Therapy non-responder Risk?
OLARATUMAB vs OLECLUMAB
OLARATUMAB vs OLIVE OIL\SOYBEAN OIL
OLARATUMAB vs OLMESARTAN
OLARATUMAB vs OLMESARTAN MEDOXOMIL
OLARATUMAB vs OLMETEC